文献速递角膜与眼表疾病

RIPK3/SQSTM1介导的坏死性凋亡激活NLRP3炎症小体参与干眼病

RIPK3/SQSTM1-Mediated Necroptosis Activates the NLRP3 Inflammasome in Dry Eye Disease.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

该研究在干眼病小鼠模型中探究RIPK3介导的坏死性凋亡对角膜上皮损伤和炎症的作用。结果显示RIPK3-SQSTM1轴促进MLKL活化和NLRP3炎症小体激活,坏死性凋亡抑制剂Necrostatin-1可保护角膜上皮完整性并抑制炎症小体活化。

要点

  • RIPK3-SQSTM1轴是干眼角膜上皮损伤和炎症的关键驱动通路。
  • 坏死性凋亡抑制剂Necrostatin-1在体内保护角膜上皮并抑制炎症小体活化。
  • SQSTM1独立于经典自噬流促进MLKL活化和坏死性凋亡。

核心结论

  • RIPK3-SQSTM1-NLRP3信号轴是干眼病角膜上皮损伤和炎症的关键驱动因素,坏死性凋亡是有前景的治疗靶点。

研究设计与样本

  • 建立东莨菪碱氢溴酸盐和干燥应激诱导的干眼小鼠模型,通过荧光素染色、SEM和TEM评估角膜损伤。
  • 采用RNA测序、KEGG和基因集富集分析探索分子机制。
  • 利用RIPK3敲除、NLRP3敲除、AAV介导过表达和siRNA敲低验证RIPK3和NLRP3的致病作用。
  • 在体内评估坏死性凋亡抑制剂Necrostatin-1的治疗潜力。

主要发现

  • RNA测序和KEGG分析显示干眼角膜上皮中TNF信号通路和坏死性凋亡标志物RIPK3、MLKL显著上调。
  • RIPK3敲低显著减轻角膜上皮损伤和细胞死亡,而局部RIPK3过表达加剧上皮损伤和炎症反应。
  • SQSTM1作为RIPK3的关键下游介质,独立于经典自噬流促进MLKL活化和坏死性凋亡。
  • RIPK3-SQSTM1轴直接放大NLRP3炎症小体激活,将上皮细胞死亡与持续炎症信号联系起来。
  • 干燥应激在人角膜上皮细胞中诱导快速且持续的RIPK3-MLKL活化,Necrostatin-1在体内保留角膜上皮完整性并抑制炎症小体活化。

临床怎么用

  • 坏死性凋亡抑制剂Necrostatin-1在干眼小鼠模型中保护角膜上皮完整性并抑制炎症小体活化,提示靶向RIPK3-SQSTM1-NLRP3轴可能成为干眼病治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Dry eye disease (DED) is characterized by progressive corneal epithelial damage and chronic inflammation, yet the specific cell death mechanisms underlying epithelial loss remain unclear. This study investigated the role of RIPK3-mediated necroptosis in corneal epithelial injury and inflammation in DED. METHODS: A DED murine model was established using scopolamine hydrobromide and desiccative stress. Corneal damage was assessed via fluorescein staining, SEM, and TEM. Molecular mechanisms were explored through RNA-sequencing, Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis. The pathogenic role of RIPK3 and NLRP3 was validated using knockout (RIPK3-/-, NLRP3-/-), AAV-mediated overexpression, and siRNA knockdown. The therapeutic potential of the necroptosis inhibitor Necrostatin-1 was evaluated in vivo. RESULTS: RNA-sequencing and KEGG analysis identified the TNF signaling pathway and necroptosis markers (RIPK3, MLKL) were significantly upregulated in DED corneal epithelium. RIPK3 knockdown markedly alleviated corneal epithelial damage and cell death, whereas localized RIPK3 overexpression exacerbated epithelial injury and inflammatory responses. Mechanistically, SQSTM1 act as a critical downstream mediator of RIPK3, promoting MLKL activation and necroptosis independently of canonical autophagic flux. Further analyses demonstrated that the RIPK3-SQSTM1 axis directly amplified NLRP3 inflammasome activation, thereby linking epithelial cell death to sustained inflammatory signaling. Consistently, desiccative stress induced rapid and persistent RIPK3-MLKL activation in human corneal epithelial cells, whereas Necrostatin-1 preserved corneal epithelial integrity and suppressed inflammasome activation in vivo. CONCLUSIONS: This study identifies a RIPK3-SQSTM1-NLRP3 signaling axis as a key driver of corneal epithelial damage and inflammation in DED. These findings provide mechanistic insight into ocular surface epithelial loss and highlight necroptosis as a promising therapeutic target for DED.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Wang B, Zuo X, Zhang R, et al. RIPK3/SQSTM1-Mediated Necroptosis Activates the NLRP3 Inflammasome in Dry Eye Disease. Invest Ophthalmol Vis Sci. 2026. PMID: 42346025. doi:10.1167/iovs.67.6.48

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。